BIOADVOCATE BENCHMARK

In a landscape where advocacy and patient engagement teams struggle with limited resources and growing demands, the BIOADVOCATE Benchmark is more essential than ever.

BIOADVOCATE BENCHMARK

WHY INDUSTRY BENCHMARKING?

In a landscape where advocacy and patient engagement teams face cuts, the BIOADVOCATE Benchmark is essential. It benchmarks team sizes, budgets, and alignments against the industry, highlighting their value. This data helps these teams argue for the resources they need, showcasing their critical role in both patient outcomes and strategic insights. The BIOADVOCATE Benchmark isn’t just a report—it’s a tool for survival and growth, making a strong case for the sustained support of advocacy and engagement efforts in the face of budget constraints.

THE RESEARCH

RESEARCH DESIGN & METHODOLOGY

The team behind the BIOADVOCATE Benchmark has developed a comprehensive, yet concise research study that will go out to the broad pharmaceutical and biotech patient advocacy and health equity team members. The study includes feedback on domains like:

Team Structure & Tenure & Leveling
Team Organizational Integration & Alignment
Pipeline Engagement
Your External Engagement Approach with the Community & Patients
Budget, Resources & Training for Advocacy & Health Equity Roles

THE VALUE

EQUIPPING YOUR TEAM FOR SUCCESS

The BIOADVOCATE Benchmark research equips patient advocacy teams in biotechandpharmaceutical companies with vital insights to:

Align Strategically: Compare operations to industry standards for better performance.
Advocate Effectively: Use data to secure necessary funding and resources.
Maximize Impact: Identify strategies for greater efficiency and patient outcomes.
Increase Credibility: Leverage insights for internal recognition.
Plan with Precision: Set realistic, benchmark-informed goals.
Justify Resources: Defend and request budgets with solid evidence.
Gain Competitive Edge: Understand and capitalize on industry positioning.